Screener
Indivior Pharmaceuticals, Inc. INDV Net debt
Discontinued — last reported Q1 '26
Net debt at other companies
Other financials
Where this comes from
Calculated from Indivior Pharmaceuticals, Inc.’s reported figures.
The source filing: Indivior Pharmaceuticals, Inc.’s 10-Q, filed April 30, 2026. Open the filing →
- Filed
- Apr 30, 2026, 4:02 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001628280-26-028850
FAQ
- What is Indivior Pharmaceuticals, Inc.'s net debt?
- Indivior Pharmaceuticals, Inc. (INDV) reported net debt of $334M in Q1 2026.
- How has Indivior Pharmaceuticals, Inc.'s net debt changed year-over-year?
- Indivior Pharmaceuticals, Inc.'s net debt increased by 16800.0% year-over-year, from -$2M to $334M.
- What is the long-term trend for Indivior Pharmaceuticals, Inc.'s net debt?
- Over 2 years (2023 to 2025), Indivior Pharmaceuticals, Inc.'s net debt has grown at a 117.4% compound annual growth rate (CAGR), from -$33M to $156M.
- What does net debt mean?
- Total debt minus cash and equivalents at the quarter end. The debt that would remain if the company used all its cash to pay down borrowings.
Ask your AI about Indivior Pharmaceuticals, Inc.'s net debt.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude